Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Zomedica Pharmaceuticals Q4 Sales $6.20M Inline

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.
byMichael Horton
March 15, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts